Tuesday's ETF with Unusual Volume: IWX
Today 14:58 EDT
The iShares Russell Top 200 Value Index Fund (IWX) is seeing unusually high volume in afternoon trading Tuesday, with over 207,000 shares traded versus three month average volume of about 41,000.... Read More
category
ETFs
from ETF Channel
The NIH Aims To Develop Drugs That Big Pharma Discarded
Today 12:16 EDT
This morning, the National Institutes of Health awarded $12.7 million to nine academic groups to test potential medicines for diseases including Alzheimer's disease, Duchenne muscular dystrophy, and... Read More
from Forbes Real Time
Supreme Court Permits Antitrust Scrutiny Of Pharma Settlements
Today 10:13 EDT
In a ruling that is likely to have a far-reaching impact on the pharmaceutical industry, the Supreme Court permitted antitrust scrutiny of reverse pay settlements used between brand name drug makers... Read More
from Forbes Real Time
Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes Market
Today 10:00 EDT
category
Pharmaceuticals
from Trefis
A New York court designated a pension fund as the lead plaintiff in a lawsuit filed by shareholders of Elan against SAC Capital. Read More
from FOX News
June 18 (Reuters) - A New York court designated a pension fund as the lead plaintiff in a lawsuit filed by shareholders of Elan Corp against SAC Capital, a court filing showed, as the hedge fund... Read More
category
companyNews
Stock in pSivida Corp. (Nasdaq: PSDV) rose 9 percent Monday after its treatment for some types of chronic diabetic macular edema (DME) was deemed cost effective by a UK agency, and the company was... Read More
from Business Journals
Building on its strategy to boost partnerships and securing deals with more than 18 new partners this year, Datawatch Corp... Read More
from Business Journals
BCG Weighs In On First-In-Class Vs. Best-In-Class Drugs -- How Valuable Is Their Advice?
June 17, 2013
The hardest decisions facing a head of a pharmaceutical R&D organization involve determining which great ideas to fund. One might think this is a simple process, that any idea which can lead to a new... Read More
from Forbes Real Time
Pfizer - Roundup Review
June 17, 2013
from AVAFIN
LONDON, June 17 (Reuters) - British scientists have won early financial backing for a new kind of anticoagulant drug they believe may prevent dangerous blood clots without causing bleeding - a... Read More
category
companyNews
Friday's ETF with Unusual Volume: XPH
June 14, 2013
The SPDR S&P Pharmaceuticals ETF (XPH) is seeing unusually high volume in afternoon trading Friday, with over 119,000 shares traded versus three month average volume of about 40,000. Shares of XPH were... Read More
category
ETFs
from ETF Channel
BioLabs' shareholder questions ROI
June 14, 2013
Jeffrey Chokel, a longtime Cleveland BioLabs Inc. shareholder from Shaker Heights, Ohio, cut right to the chase at the company’s annual shareholder meeting Friday morning... Read More
from Business Journals
category
Pharmaceuticals
,
Medical Devices & Supplies
from Trefis
from ACCESSWIRE
VTV, GE, PFE, T: Large Inflows Detected at ETF
June 13, 2013
Symbols mentioned in this story: VTV, GE, PFE, T Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can... Read More
category
ETFs
from ETF Channel
The most recent short interest data has been released by the NASDAQ for the 05/15/2013 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying... Read More
category
Stocks
from Market News Video
Three directors of cancer drug company Verastem Inc. and its founding executive chairman have purchased $475,000 worth of the company’s stock in the past week as it plans to start a potential pivotal... Read More
from Business Journals
INSIGHT-No smoke, plenty of fire fuels e-cigarettes
June 13, 2013
category
companyNews
PRESS DIGEST - Wall Street Journal - June 13
June 13, 2013
June 13 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. Read More
category
companyNews
Biotech Value Investments For 2013 With No Approval Risk
June 12, 2013
category
Pharmaceuticals
from Trefis
Equities skidded to a third straight day of losses in New York Wednesday after early gains evaporated. A week light on economic data and smack in the barren desert of corporate reports between earnings... Read More
from Forbes Real Time
After 10-year fight, Pfizer wins huge patent settlement
June 12, 2013
Teva Pharmaceuticals Industries Ltd. and Sun Pharmaceutical Industries Ltd. have agreed to pay Pfizer Inc... Read More
from Business Journals
Stocks Lower, All S&P Sectors Dip; Dollar Drops
June 12, 2013
Stocks quickly cut their early gains to turn lower in choppy trading Wednesday, extending sharp losses from the previous session, as the dollar plunged against the yen and amid lingering worries of Fed... Read More
from CNBC.com News
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here